Trial intelligence / Profile preview

Home-based Phase IIb dose-finding study of inhaled VR004 (apomorphine) in erectile dysfunction

2004-004464-69Phase 2Completed

Sponsor
Vectura
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in erectile dysfunction (ED) comparing Inhaled apomorphine (VR004) dose-finding arm with Placebo arm (2 arms). Primary endpoint: Change in proportion of "yes" responses. Started Feb 2005; status: completed.

02

Drugs

apomorphine
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2004-004464-69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004464-69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call